[State of immunological reactivity in breast cancer patients receiving prednisolone treatment]. 1979

E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006914 Hydroxysteroids Steroids in which one or more hydroxy groups have been substituted for hydrogen atoms either within the ring skeleton or on any of the side chains.

Related Publications

E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
January 1982, The Indian journal of chest diseases & allied sciences,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
January 1984, Voprosy onkologii,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
January 1977, Developments in biological standardization,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
July 1977, Klinicheskaia meditsina,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
August 2023, CJC open,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
January 1963, Problemy tuberkuleza,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
April 2017, Journal of cachexia, sarcopenia and muscle,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
January 1978, Voprosy onkologii,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
October 2014, Psycho-oncology,
E V Tsyrlina, and S N Fedorov, and T E Poroshina, and V P Buslaeva, and I K Seleznev
September 1980, Vrachebnoe delo,
Copied contents to your clipboard!